Methylphenidate in tardive dyskinesia.
D000284:Administration, Oral; D001480:Basal Ganglia Diseases / Q000188:drug therapy; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D006801:Humans; D001523:Mental Disorders / Q000139:chemically induced / Q000188:drug therapy; D008774:Methylphenidate / Q000008:administration & dosage / Q000627:therapeutic use*; D009069:Movement Disorders / Q000139:chemically induced / Q000175:diagnosis / Q000188:drug therapy*; D010919:Placebos; D012075:Remission, Spontaneous; D014149:Tranquilizing Agents / Q000009:adverse effects / Q000627:therapeutic use
D010919:Placebos; D014149:Tranquilizing Agents; D008774:Methylphenidate